4.4 Article

Protection against advanced glycation end products and oxidative stress during the development of diabetic keratopathy by KIOM-79

期刊

JOURNAL OF PHARMACY AND PHARMACOLOGY
卷 63, 期 4, 页码 524-530

出版社

WILEY
DOI: 10.1111/j.2042-7158.2010.01206.x

关键词

advanced glycation end products; apoptosis; diabetic keratopathy; KIOM-79

资金

  1. Korea Institute of Oriental Medicine (KIOM) [L08010, K09030]
  2. Ministry of Education, Science & Technology (MoST), Republic of Korea [L08010] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Objectives KIOM-79 is a mixture of 80% ethanol extracts of parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix. The preventive effect of KIOM-79 on the development of diabetic keratopathy has been investigated. Methods Seven-week-old male Zucker diabetic fatty (ZDF) rats were treated with KIOM-79 (50 mg/kg body weight) once a day orally for 13 weeks. The thickness of the cornea was measured and the extent of corneal cell death was detected by a terminal deoxynucleotidyl transferase dUTP nick-end labelling assay. The expression of advanced glycation end products (AGEs), 8-hydroxydeoxyguanosine, nuclear factor-kappaB (NF-kappa B), Bax and Bcl-2 were evaluated in corneal tissues. Key findings The administration of KIOM-79 prevented corneal oedema and apoptotic cell death of corneal cells. The accumulation of AGE in corneal tissues was reduced in ZDF rats treated with KIOM-79. Moreover, KIOM-79 attenuated oxidative DNA damage, NF-kappa B activation and Bax overexpression in the cornea. Conclusions The results suggested that KIOM-79 exhibited corneal protective properties by not only reducing oxidative stress but inhibiting the AGEs/NF-kappa B downstream signal pathway during the development of diabetic keratopathy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据